Skip to content
MARKETS / NASDAQ / MLAB
NASDAQ · INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL · MID CAP

Mesa Laboratories Inc. MLAB

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$249.1M
▲ 3.4% YoY
$6.7M
$39.6M
▼ 7.0% YoY
In brief

What this company does

Mesa Laboratories designs and manufactures life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Headquartered in Lakewood, Colorado, the company has manufacturing operations in the United States and Europe, and markets its products through sales personnel in North America, Europe and the Asia Pacific region, and by independent distributors throughout the world. The company reports its financial performance in four segments, or divisions: Sterilization and Disinfection Control, Biopharmaceutical Development, Calibration Solutions, and Clinical Genomics. As of March 31, 2026, the company had 717 employees, including approximately 450 domestic employees, of whom 347 were employed for manufacturing and quality assurance, 99 for research and development and engineering, 179 for sales and marketing, and 92 for administrative functions. No customer represented more than 10% of the company's consolidated accounts receivable or revenues for fiscal year 2026. Mesa was organized in 1982 as a Colorado corporation.

Written from the business description in MESA LABORATORIES, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 3 June 2026. Every sentence was checked against that document before publication.

Growth
USD 249.1M
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 249.1 · Net income 6.7
100M200M-100M-200M201020122014201620182020202220242025
Compound annual growth
+4.4%
+13.2%
+11.4%
+14.1%
+93.3%
+15.4%
+92.4%
+13.6%
−8.6%
−2.8%
+0.0%
+0.0%
+1.1%
+2.2%
+4.3%
+5.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +13.2% a year over five years — but profit grew faster: net income at +15.4%, earnings per share at +13.6%.

The share count rose from 0.01B to 0.01B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
3 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 7.4% · Net 2.7%
10%20%30%-50%-100%201020122014201620182020202220242025
ROE
FY2025 · ROE 3.9%
5%10%15%-50%201020122014201620182020202220242025

Each USD of equity produced 4 cents of profit this year.

Cash & shareholders
USD 3.5M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 39.6
20M40M201020122014201620182020202220242025
Net buybacks $M Dividends $M
FY2025 · Dividends 3.5 · Net buybacks —
2.0M-0.8M-1.6MDividendsNet buybacks201020122014201620182020202220242025

USD 3.5M in dividends — 52% of the year's profit went back to shareholders.

Total assetsUSD 427.7M
EquityUSD 186.2M
CashUSD 26.9M
Gross debtUSD 67.5M
Net debtUSD 40.6M
Current ratio1.72×

Net debt stands at 22% of equity.

The 16-year record
16 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.20.20.20.20.20.10.10.10.10.10.10.10.10.00.00.0
Operating income $B0.00.0−0.30.00.00.00.00.00.00.00.00.00.00.00.00.0
EBITDA $B0.00.0−0.30.00.00.00.00.00.00.00.00.00.00.00.00.0
Income tax $B0.00.0−0.0−0.00.0−0.00.00.00.00.00.00.00.00.00.00.0
Net income $B0.0−0.0−0.30.00.00.00.00.0−0.00.00.00.00.00.00.00.0
Free cash flow $B0.00.00.00.00.00.00.00.00.0·······
EPS, diluted $1.21−0.36−47.200.170.350.640.411.86−0.792.912.972.632.492.352.291.86
Dividend / sh $0.640.640.640.640.640.640.640.64········
Payout %52−176−13661789715333−8121212322212124
ROE %3.9−1.3−94.40.20.51.01.17.1−3.012.314.113.915.417.519.717.0
Shares out B0.010.010.010.010.010.010.000.000.000.000.000.000.000.000.000.00

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 80 reconciliationsAUDITED

Reconciled in 16 of 19 fiscal years. 15 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityIndustrial Instruments For Measurement, Display, and Control
Listed onNASDAQ
Incorporated inColorado
Fiscal year endsMarch 31
Data on record since2010

Share this section

Download image